Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹10,233 Cr₹5.27 Cr₹-740 Cr₹605 Cr₹-7.81 Cr

What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?

The latest Cash Flow from Financing Activities ratio of MANKIND PHARMA is ₹10,233 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹10,233 Cr
Mar2024₹5.27 Cr
Mar2023₹-740 Cr
Mar2022₹605 Cr
Mar2021₹-7.81 Cr

How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹10,233 Cr
194,066.22
Mar2024 ₹5.27 Cr
Positive
Mar2023 ₹-740 Cr
Negative
Mar2022 ₹605 Cr
Positive
Mar2021 ₹-7.81 Cr -

Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,597.3 Cr -3.7% -3.3% -8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,682.0 Cr -2% 2% -16.2% Stock Analytics
DIVIS LABORATORIES ₹150,985.0 Cr -5% -6.6% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,862.0 Cr -0.4% 0.5% 5.2% Stock Analytics
CIPLA ₹121,294.0 Cr -2.4% -5.4% -8.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,132.0 Cr -5.8% -4.4% -8.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-3.7%

-3.3%

-8.3%

SENSEX

-2.2%

0.6%

-5.8%


You may also like the below Video Courses